SEC Filings

Form F-1/A
AURIS MEDICAL HOLDING AG filed this Form F-1/A on 07/03/2018
Document Outline
Entire Document (1663.2 KB)
Subdocument 1 - F-1/A - AMENDMENT NO. 1 TO FORM F-1
Page 1 - Copies to:
Page 2 - The Registrant hereby amends this registration statement on such date or dates as may be necessary t
Page 3 - The information in this prospectus is not complete and may be changed. We may not sell these securit
Page 4 - table of contents
Page 5 - N/A
Page 6 - PROSPECTUS SUMMARY
Page 7 - Nasdaq Listing Requirements and Merger
Page 8 - Offering of Common Shares and Warrants
Page 9 - Capital Increase
Page 10 - THE OFFERING
Page 11 - N/A
Page 12 - N/A
Page 13 - RISK FACTORS
Page 14 - Provisions of the warrants and pre-funded warrants offered by this prospectus could discourage an ac
Page 15 - In the event that our common shares are delisted from Nasdaq, U.S. broker-dealers may be discouraged
Page 16 - N/A
Page 17 - PRESENTATION OF FINANCIAL AND OTHER INFORMATION
Page 18 - CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Page 19 - N/A
Page 20 - USE OF PROCEEDS
Page 21 - DIVIDEND POLICY
Page 22 - MARKET FOR OUR COMMON SHARES
Page 23 - CAPITALIZATION
Page 24 - N/A
Page 25 - DILUTION
Page 26 - N/A
Page 27 - EXCHANGE RATES
Page 28 - PRINCIPAL SHAREHOLDERS
Page 29 - Holders
Page 30 - DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION
Page 31 - genehmigtes Kapital
Page 32 - Erm chtigungsbeschlussKapitalerh hungsberichtFeststellungsbeschluss
Page 33 - Uncertificated Securities
Page 34 - Voting and Quorum Requirements
Page 35 - Agenda Requests
Page 36 - Transfer of Shares
Page 37 - Board of Directors
Page 38 - Indemnification of Executive Management and Directors
Page 39 - Borrowing Powers
Page 40 - Notification and Disclosure of Substantial Share Interests
Page 41 - Description of Warrants
Page 42 - Exercise Price
Page 43 - Description of Pre-Funded Warrants
Page 44 - Exercise Limitations
Page 45 - No Exchange Listing
Page 46 - Comparison of Swiss Law and Delaware Law
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - Taxation
Page 53 - Individual and Corporate Income Tax on Dividends
Page 54 - BeteiligungsabzugNennwertr ckzahlungenReserven aus Kapitaleinlagen
Page 55 - Gestehungskosten
Page 56 - Tax Treatment of the Pre-Funded Warrants
Page 57 - de minimis
Page 58 - pro rata
Page 59 - Constructive Dividends on Pre-Funded Warrants and Warrants
Page 60 - Information Reporting and Backup Withholding
Page 61 - UNDERWRITING
Page 62 - Indemnification
Page 63 - Passive Market Making
Page 64 - Notice to Investors in the United Kingdom
Page 65 - N/A
Page 66 - Expenses of the Offering
Page 67 - Legal Matters
Page 68 - Enforcement of Judgments
Page 69 - Where You Can Find More Information
Page 70 - N/A
Page 71 - PART II
Page 72 - Item 8. Exhibits
Page 73 - N/A
Page 74 - Item 9. Undertakings
Page 75 - N/A
Page 76 - N/A
Page 77 - SIGNATURES
Page 78 - N/A
Page 79 - EXHIBIT INDEX
Page 80 - N/A
Subdocument 2 - EX-1.1 - EXHIBIT 1.1
Page 1 - Exhibit 1.1
Page 2 - Final Prospectus. The Final Prospectus, the Pricing Prospectus and any preliminary prospectus in the
Page 3 - Section 1. Representations and Warranties of the Company.
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - Section 2. Purchase, Sale and Delivery of the Offered Securities.
Page 17 - N/A
Page 18 - Section 3. Capital Increase and Initial Subscription.
Page 19 - Firm Capital Increase Amount ) with the Capital Increase Bank on the Firm Capital Increase Account,
Page 20 - DTC ) on the First Closing Date; and (B) freely transferable (subject to any applicable restrictions
Page 21 - Over-Allotment Capital Increase Amount ) with the Capital Increase Bank, in the Over-Allotment Capit
Page 22 - Section 5. Additional Covenants of the Company.
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - Section 6. Payment of Expenses. The Company agrees to pay all costs, fees and expenses incurred in c
Page 30 - Section 8. Conditions of the Obligations of the Underwriters. The obligations of the Underwriters he
Page 31 - N/A
Page 32 - Section 9. Reimbursement of Representative s Expenses. If this Agreement is terminated by the Repres
Page 33 - Section 11. Indemnification.
Page 34 - Section 12. Contribution. If the indemnification provided for in Section 11 shall for any reason be
Page 35 - Section 13. [Reserved]
Page 36 - Call Option ) to request in writing that the Representative deliver the Firm Shares or Applicable Op
Page 37 - Capital Reduction ) by cancellation of the Firm Shares or Applicable Optional Shares, as applicable,
Page 38 - Section 16. No Advisory or Fiduciary Relationship. The Company acknowledges and agrees that (a) the
Page 39 - Section 18. Notices. All communications hereunder shall be in writing and shall be mailed, hand deli
Page 40 - Section 21. Governing Law Provisions; Currency Provisions. This Agreement shall be governed by and c
Page 41 - Section 22. General Provisions. This Agreement constitutes the entire agreement of the parties to th
Page 42 - N/A
Page 43 - N/A
Page 44 - Schedule I
Page 45 - Schedule A
Page 46 - Schedule B
Page 47 - Exhibit A
Page 48 - Exchange Act ), shall be required or shall be voluntarily made in connection with such transfers; (b
Page 49 - N/A
Page 50 - Exhibit B
Page 51 - Exhibit C
Page 52 - [Company Name Subscriber]
Page 53 - Exhibit D
Page 54 - [Company Name Subscriber]
Subdocument 3 - EX-1.2 - EXHIBIT 1.2
Page 1 - Exhibit 1.2
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Subdocument 4 - EX-4.6 - EXHIBIT 4.6
Page 1 - Exhibit 4.6
Page 2 - N/A
Page 3 - The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - EXHIBIT A
Page 18 - N/A
Page 19 - EXHIBIT B
Subdocument 5 - EX-4.7 - EXHIBIT 4.7
Page 1 - Exhibit 4.7
Page 2 - N/A
Page 3 - The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
Page 4 - CHF [_____], subject to adjustment hereunder (the Exercise Price ). In no event shall the Exercise P
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - EXHIBIT A
Page 19 - EXHIBIT B
Subdocument 6 - EX-5.1 - EXHIBIT 5.1
Page 1 - Exhibit 5.1
Page 2 - Documents):
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Subdocument 7 - EX-5.2 - EXHIBIT 5.2
Page 1 - Exhibit 5.2
Page 2 - N/A
Subdocument 8 - EX-23.1 - EXHIBIT 23.1
Page 1 - N/A